Claim
An MIT-developed lipid nanoparticle formulation kept RNA vaccine particles stable at room temperature for up to one year or at 37°C (98°F) for two months.
a conjunction joins clauses that may be separately evaluableTopics
Medicine · 1efd24fe Vaccines · 1efd24fe
Assessment
Supported
Main unresolved issue: 5 counted evidence items have no independence review; repeats of one origin may be counted as several coverage:f87b7afb-1da3-8032-a1de-4ae80171cfbc
Not yet independently audited.Evidence points both ways.Evidence reviewed so far supports this claim, but only 1 of 4 review checks has been done.A quoted passage from news.mit.edu was not found on the page when Galedra fetched it.
Why?
Strongest counted support: MIT reports one-year room-temperature or two-month 98°F storage stability and equivalent immune responses in mice after storage. weight 2.000000 evidence
Strongest counted contradiction: An independent 2026 study of four liquid mRNA-LNP formulations found degradation at 5°C and complete transfection loss at 25°C within six months. weight 0.200000 evidence
Suppressed as dependent: The passage directly states that the formulation remained stable at room temperature for one year or nearly 100 degrees Fahrenheit for two months.
Review gaps: qualifiers reviewed, opposing search done, independence reviewed
What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Supported.
Your view
Registered views
Nobody has registered a view yet.
Checked as part of
- “An MIT-developed lipid nanoparticle formulation kept RNA vaccine particles stable at room temperature for up to one year or at 37°C (98°F) for two months.” · 1 claim · 29 September 2026
- “An MIT-developed lipid nanoparticle formulation kept RNA vaccine particles stable at room temperature for up to one year or at 37°C (98°F) for two months.” · 1 claim · 28 September 2026
- “MIT researchers developed an AI-optimized lipid nanoparticle formulation that kept RNA vaccine particles stable at room temperature for a year or at 98°F for...” · 2 claims · 28 September 2026
Evidence for
-
From New formulation helps RNA vaccines withstand high temperatures Read 2026-09-28 Relevance DIRECT Steps 0 Counted
The passage directly states the storage durations and temperatures.
-
From New formulation helps RNA vaccines withstand high temperatures Read 2026-09-28 Relevance DIRECT Steps 0 Counted
-
From Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI Read 2026-09-28 Relevance DIRECT Steps 0 Counted
Peer-reviewed primary study corroborates the high-temperature stability result, with the reported two-month duration.
-
From Accelerated discovery of thermostable mRNA–lipid nanoparticle vaccines using data-efficient AI Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Independent primary article corroborates the heat-stability result while specifying the tested animal populations and solid-state formulation.
Evidence against
-
From Identifying Key Factors Affecting mRNA-Lipid Nanoparticles Drug Product Formulation Stability Read 2026-09-28 Relevance WEAK Steps 0 Counted
This challenges generalizing room-temperature stability across LNP formulations, but it does not directly test MIT’s distinct formulation or disprove its reported result.
Qualifications
None.
Suppressed as dependent
| Evidence | Group | Kept instead |
|---|---|---|
| d2b94ec5 | b8f37cd0 |
Inferences
Concluded from
None.
Used as a premise in
None.
Threads
None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.
Claim edges
None. Edges are stored and displayed; v0.1 does not propagate probability across them.
Review checklist
Review checks: 1 of 4
| Check | Done | By |
|---|---|---|
| qualifiers reviewed | no | |
| opposing search done | no | |
| independence reviewed | no | |
| primary source reviewed | yes | b8f37cd0, 3a751c49, 9659b432, 4873dbe3, 243cba70 |
Summary
Supported. The main support is: MIT reports one-year room-temperature or two-month 98°F storage stability and equivalent immune responses in mice after storage. 04d99f90
Against that, contradiction: An independent 2026 study of four liquid mRNA-LNP formulations found degradation at 5°C and complete transfection loss at 25°C within six months. 9c76b1c0
1 further item repeats the same origin and is not independent evidence. d2b94ec5
A search for evidence in the opposing direction found something; see the counted evidence. 4cd94050
Review checks: 1 of 4. coverage:f87b7afb-1da3-8032-a1de-4ae80171cfbc
Contribution history
| seq | event | detail |
|---|---|---|
| 13455 | APPENDED | |
| 13456 | ACCEPT | AUTOMATIC_AFTER_VALIDATION |
| 13465 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 13470 | TASK_RESULT | by 1efd24fe (accepted) |
| 13478 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 13885 | TASK_RESULT | by 1efd24fe (accepted) |
| 15624 | LINK_EVIDENCE | by 1efd24fe (accepted) |